01 January 2005
Experiences with three different fi ber supplements in weight reduction
Grethe Støa Birketvedt, Mona Shimshi, Erling Thom, Jon FlorholmenMed Sci Monit 2005; 11(1): PI5-8 :: ID: 13883
Abstract
Background: Fiber supplements added to a caloric diet have additional effects on weight reduction in overweight subjects. The aim of this study was to compare the effect of various commercial fiber supplements (glucomannan, guar gum and alginate) on weight reduction in healthy overweight subjects. Material/Methods: One hundred and seventy six men and women were included to receive either active fi ber substance or placebo in randomized placebo-controlled studies. The fi ber supplements consisted of the viscous fi bers glucomannan (Chrombalance[sup]®[/sup]), glucomannan and guar gum (Appe-Trim[sup]®[/sup]) and glucomannan, guar gum and alginat (Glucosahl).Results: All fi ber supplements plus a balanced 1200 kcal diet induced signifi cantly weight reduction more than placebo and diet alone, during a fi ve week observation period. However, there were no signifi cant differences between the different fi bers in their ability to induce weight reduction, which was approximately 0.8 kg/week (3.8±0.9, 4.4±2.0, 4.1±0.6 in the Chrombalance, Appe-Trim[sup]®[/sup] and Glucosahl group, respectively).Conclusions: Glucomannan induced body weight reduction in healthy overweight subjects, whereas the addition of guar gum and alginate did not seem to cause additional loss of weight.
Keywords: Alginates - therapeutic use, Dietary Fiber - therapeutic use, Galactans - therapeutic use, Glucuronic Acid - therapeutic use, Hexuronic Acids - therapeutic use, Mannans - therapeutic use, Weight Loss - drug effects, Alginates - therapeutic use, Dietary Fiber - therapeutic use, Galactans - therapeutic use, Glucuronic Acid - therapeutic use, Hexuronic Acids - therapeutic use, Mannans - therapeutic use, Obesity - diet therapy, Plant Gums, Weight Loss - drug effects
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952